<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:department>Research and Enterprise Services</gtr:department><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8967420-49D3-4509-9912-25FB3EC75B74"><gtr:id>A8967420-49D3-4509-9912-25FB3EC75B74</gtr:id><gtr:name>University of Sussex</gtr:name><gtr:address><gtr:line1>The Administration</gtr:line1><gtr:line2>Sussex House</gtr:line2><gtr:line3>Falmer</gtr:line3><gtr:line4>Brighton</gtr:line4><gtr:line5>East Sussex</gtr:line5><gtr:postCode>BN1 9RH</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7035AE5D-F006-4762-9959-D965363291F6"><gtr:id>7035AE5D-F006-4762-9959-D965363291F6</gtr:id><gtr:name>Merck</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7561CBD8-8D97-4798-B555-3F2F4AC52FDC"><gtr:id>7561CBD8-8D97-4798-B555-3F2F4AC52FDC</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Norman</gtr:otherNames><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/36615221-6D4C-4D80-BBEC-B49B39355866"><gtr:id>36615221-6D4C-4D80-BBEC-B49B39355866</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:surname>King</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6547C0B1-68FD-4409-86CB-C572B354DE96"><gtr:id>6547C0B1-68FD-4409-86CB-C572B354DE96</gtr:id><gtr:firstName>Jeremy</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Lambert</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E4AE7901-605D-408B-93B7-91A4C5F99ED5"><gtr:id>E4AE7901-605D-408B-93B7-91A4C5F99ED5</gtr:id><gtr:firstName>Delia</gtr:firstName><gtr:surname>Belelli</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/4C02D2B4-F889-4121-8837-D9F9D5D290F1"><gtr:id>4C02D2B4-F889-4121-8837-D9F9D5D290F1</gtr:id><gtr:firstName>Theodora</gtr:firstName><gtr:surname>Duka</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000008"><gtr:id>B0D02070-D808-470D-8902-5AB7637FF171</gtr:id><gtr:title>GABA-A receptors in accumbens neural circuits underlying drug abuse: novel targets for treatment?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000008</gtr:grantReference><gtr:abstractText>Drug addiction is a major social and health problem with causes that are both social and biological. The project represents the first stage of a programme of work whose aim is i) to develop methods in non-addicted volunteers for studying forms of addiction and its treatment (experimental medicine), ii) to understand particular biological processes that underlie addictive behaviour, and iii) to identify potential targets for pharmacological or behavioural intervention to combat forms of addictive behaviour. Some of our aims will be delivered within the lifetime of this proposal, while others will be realised in extensions of the work outlined here, and in parallel proposals under the umbrella of the MRC Addiction Research Cluster ?GABA?. In the present proposal we will study people who carry one particular genetic risk for addiction to discover how their behaviour is altered in ways that might increase the likelihood of developing addictions. At the same time, we will study the brain mechanisms involved in the action of this, and related genes, with the hope of finding ways in which the genetic predisposition can be overcome, either with drug-treatment or by changing their risky behaviour.</gtr:abstractText><gtr:technicalSummary>GABAergic neurons are intimately involved in several brain systems that play decisive roles in development of addictions, but their particular importance has not hitherto been a focus of research. We have recently provided evidence of a role for the alpha2-subtype of GABA-A receptor in the function of accumbens motivational systems in mice, and demonstrated a genetic association between haplotypes of the gene encoding this subunit and human cocaine addiction (Dixon et al, PNAS, 2010). We will now study in non-addicted human volunteers whether such haplotypes give rise to biomarkers for addiction, and behavioural endophenotypes that may confer risk for development of addictive behaviours, particularly as a consequence of stressors. In parallel, we will use genetic manipulations of mouse genes encoding the alpha2, and other subtypes (alpha4,alpha5, and delta subtypes) of GABA-A receptor, and drugs specific to such subtypes, to study the consequences of such manipulation on the function of accumbal medium spiny neurons, and for behaviours known to model aspects of addiction-related behaviours in mice. We will thus develop methods for studying therapeutic effects in humans, as well as identify potential pharmacological and behavioural targets for future therapies.</gtr:technicalSummary><gtr:fund><gtr:end>2014-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>999999</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Merck</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>provision of genetically manipulated mice</gtr:description><gtr:id>F135AE2A-7562-4FC3-9A6D-6351A6B0EA48</gtr:id><gtr:impact>PMD 19501766 PMD 18313124 PMD 18358520 PMD 16706856</gtr:impact><gtr:outcomeId>E2E10E3F0F5-1</gtr:outcomeId><gtr:partnerContribution>Partner provided 2 strains of genetically manipulated mice</gtr:partnerContribution><gtr:piContribution>Behavioural and neurobiological characterisation of genetically manipulated mice</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIH INIA Stress Consortium</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>870F50E6-A325-4C73-99F0-E3BAE4363BC8</gtr:id><gtr:outcomeId>eBfDNPd75yY</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal College of Psychiatry</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8CB56680-2C56-46D2-AE02-D280EA649B4C</gtr:id><gtr:outcomeId>et5kUHPLs1d</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E5BA512A-3754-43B3-BD9F-2FCB5C1AA711</gtr:id><gtr:title>Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24c89a46bc4fc9d556fe9b4dc2be9826"><gtr:id>24c89a46bc4fc9d556fe9b4dc2be9826</gtr:id><gtr:otherNames>Anstee QM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_540e14de14d1361bd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0123D76-03C7-4AA5-AF94-0F1EB06ACBB0</gtr:id><gtr:title>Rodent models of treatment-resistant depression.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/355806f74d831ab52abec23cc4160185"><gtr:id>355806f74d831ab52abec23cc4160185</gtr:id><gtr:otherNames>Caldarone BJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>5a2fda736d4ad6.41759173</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A07C113-D053-4295-B2CA-FAC5621769F1</gtr:id><gtr:title>Deficiency of Cks1 Leads to Learning and Long-Term Memory Defects and p27 Dependent Formation of Neuronal Cofilin Aggregates.</gtr:title><gtr:parentPublicationTitle>Cerebral cortex (New York, N.Y. : 1991)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42072413975c4d722c05ea5a2a836f02"><gtr:id>42072413975c4d722c05ea5a2a836f02</gtr:id><gtr:otherNames>Kukalev A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1047-3211</gtr:issn><gtr:outcomeId>5a35dafeb96b56.16120822</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55E3E4B5-C163-4930-8591-5E84CF1034C8</gtr:id><gtr:title>Benzodiazepines: risks and benefits. A reconsideration.</gtr:title><gtr:parentPublicationTitle>Journal of psychopharmacology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e6466fa42b7c337cb5383a05be3dad9"><gtr:id>1e6466fa42b7c337cb5383a05be3dad9</gtr:id><gtr:otherNames>Baldwin DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0269-8811</gtr:issn><gtr:outcomeId>doi_13472_1113503509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E8481F9-ED46-4BA6-8A0F-1E8734092705</gtr:id><gtr:title>Motivational Effects of Methylphenidate are Associated with GABRA2 Variants Conferring Addiction Risk.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>585d691f4b7b32.93519880</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56252036-8656-4C04-BCF9-8EAC352889E4</gtr:id><gtr:title>GABAreceptor subtype involvement in addictive behaviour.</gtr:title><gtr:parentPublicationTitle>Genes, brain, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9648c427cf7e119d5c5bc458f6e0ef"><gtr:id>cf9648c427cf7e119d5c5bc458f6e0ef</gtr:id><gtr:otherNames>Stephens DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1601-183X</gtr:issn><gtr:outcomeId>58b5561939d094.08424540</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C14BCB8E-9D02-41E3-86DD-887A762FFE8E</gtr:id><gtr:title>Tonic inhibition of accumbal spiny neurons by extrasynaptic a4?d GABAA receptors modulates the actions of psychostimulants.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f1090fb8dc6db808afca861cb7bace0"><gtr:id>0f1090fb8dc6db808afca861cb7bace0</gtr:id><gtr:otherNames>Maguire EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_540e170e170b4125c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>018CBEC3-E637-466F-81A5-D0F988F6B236</gtr:id><gtr:title>A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/139db7cc41cacc17c531525b6b29defa"><gtr:id>139db7cc41cacc17c531525b6b29defa</gtr:id><gtr:otherNames>Jensen ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>doi_55f985985580f05c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>902DF3AA-ACBF-4B0E-AAB4-49ADB259BA72</gtr:id><gtr:title>Deletion of the GABAA a2-subunit does not alter self administration of cocaine or reinstatement of cocaine seeking.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d86a37a8e51f63a523c035fb39e6196"><gtr:id>0d86a37a8e51f63a523c035fb39e6196</gtr:id><gtr:otherNames>Dixon CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_540e14de14d1da6c9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F523F2BB-5743-41F1-9EC4-24C3DE6994A2</gtr:id><gtr:title>Deletion of the gabra2 gene results in hypersensitivity to the acute effects of ethanol but does not alter ethanol self administration.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0d86a37a8e51f63a523c035fb39e6196"><gtr:id>0d86a37a8e51f63a523c035fb39e6196</gtr:id><gtr:otherNames>Dixon CI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>doi_55f9849840930a78</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED613E44-7E42-4F38-8672-00ABE67130E4</gtr:id><gtr:title>Distinct mechanisms regulate GABAA receptor and gephyrin clustering at perisomatic and axo-axonic synapses on CA1 pyramidal cells.</gtr:title><gtr:parentPublicationTitle>The Journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed509ddca3263f1e05b2db1df46f080d"><gtr:id>ed509ddca3263f1e05b2db1df46f080d</gtr:id><gtr:otherNames>Panzanelli P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3751</gtr:issn><gtr:outcomeId>pm_13472_22_21825022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17C98961-39EB-47CB-AA68-7FF5ADB862FD</gtr:id><gtr:title>Measuring impulsivity in mice: the five-choice serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c71d11dbecfbc87609cdb94361cae07"><gtr:id>8c71d11dbecfbc87609cdb94361cae07</gtr:id><gtr:otherNames>Sanchez-Roige S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>pm_13472_22_22089700</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>611FAE94-3EBF-4EA4-A382-03E6B072FCBB</gtr:id><gtr:title>Extrasynaptic glycine receptors of rodent dorsal raphe serotonergic neurons: a sensitive target for ethanol.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f1090fb8dc6db808afca861cb7bace0"><gtr:id>0f1090fb8dc6db808afca861cb7bace0</gtr:id><gtr:otherNames>Maguire EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn><gtr:outcomeId>doi_55f985985576ad15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48209CFD-D4AF-48E5-A6B4-33493E175D51</gtr:id><gtr:title>Single Nucleotide Polymorphism Associated with Altered Brain Responses (but not Performance) during Measures of Impulsivity and Reward Sensitivity in Human Adolescents.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb946697bc0f9579fb05719e815034d2"><gtr:id>bb946697bc0f9579fb05719e815034d2</gtr:id><gtr:otherNames>Duka T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn><gtr:outcomeId>58c6abe61bd456.57812294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15709C9D-87E1-4080-B42E-F99BD1531D44</gtr:id><gtr:title>Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypes.</gtr:title><gtr:parentPublicationTitle>Addiction biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a18bfc7707aff90dd40d5eab68c9e6c0"><gtr:id>a18bfc7707aff90dd40d5eab68c9e6c0</gtr:id><gtr:otherNames>Leeman RF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1355-6215</gtr:issn><gtr:outcomeId>doi_13472_9_00192_x_</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DEC2A6D-04E6-4CB4-8310-66BB12E06062</gtr:id><gtr:title>Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5778e2c038c0477f0fed58629a850fa8"><gtr:id>5778e2c038c0477f0fed58629a850fa8</gtr:id><gtr:otherNames>Ripley TL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>ay7vQBM7wNB</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000008</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>